Population
2155 patients with hypertrophic cardiomyopathy (HCM) in Japan (survival analysis performed on n=1605).
Design
Cohort
Follow-up
up to 5 years
Authors
Loading...
May refine HCM risk stratification; extends observational cohorts but leaves open prospective validation before practice change.
In a nationwide Japanese cohort of HCM patients, higher cardiothoracic ratio, lower LVEF, and LBBB were independent predictors of poorer 5-year survival, whereas apical hypertrophy predicted better survival.
Nasermoaddeli et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: